Prevalence of Oropharyngeal Candidiasis and distribution of Candida species among People Living with Human Immunodeficiency Virus in Africa: a systematic review and meta-analysis
Authors:
- Benson MusinguziBMBenson Musinguzi
- Ekwaro A. ObukuEOEkwaro A. Obuku
- Alison Annet KinengyereAKAlison Annet Kinengyere
- Regina NdagireRNRegina Ndagire
- Andrew BagumaABAndrew Baguma
- Alex MwesigwaAMAlex Mwesigwa
- Herbert ItabangiHIHerbert Itabangi
- Gerald MboowaGerald Mboowa
- Obondo James SandeOSObondo James Sande
- Beatrice AchanBABeatrice Achan
Preprint
- 6 June 2024
- preprint
- Published by Springer Nature in Research Square
Abstract
Background: The incidence of oropharyngeal candidiasis among people living with human immunodeficiency virus in Africa is on the rise. Oropharyngeal candidiasis is mainly caused by C. albicans; however, a shift in the etiology towards non-Candida albicans species is increasing. In addition, there are variations in the epidemiological distribution of Candida species causing oropharyngeal candidiasis among people living with human immunodeficiency virus in Africa. Objective: This review aimed to determine the prevalence of oropharyngeal candidiasis and the distribution of Candida species among people living with human immunodeficiency virus in Africa. Materials and Methods: This systematic review protocol was registered in the base PROSPERO database prior to its conduct (CRD42021254473). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocol guidelines (PRISMA-P) were followed for this study. The PubMed, Scopus and EMBASE databases were searched to identify published studies published between 1st January 2000 and 8th October 2022. The eligible studies were included in the meta-analysis and analyzed using a random effects model. The risk of bias of the included studies was assessed using the Joanna Briggs Institute quality assessment tool for prevalence studies. Results: The database search yielded 370 titles from PubMed (n=192), EMBASE (n=162) and SCOPUS (n=16). Fourteen studies with a total of 3,863 participants were included in the meta-analysis. The pooled prevalence of oropharyngeal candidiasis was 49.0% (95% CI: 37% - 62%). A total of 2,688 Candida isolates were reported; approximately 76.6% (n=2,060) were C. albicans, and 21.7% (n=582) were non-C. albicans. Among the non-Candida albicans species, C. glabrata was the most common isolate (29.6%), followed by C. tropicalis (27.7%), C. krusei (17.0%), C. parapsilosis (8.1%) and C. dubliniensis (5.2%). Out of 14 studies, 7 (50.0%) had a low risk of bias, 5 (35.7%) had a moderate risk of bias, and 2 (14.3%) had a high risk of bias. Conclusion: Almost half of people living with HIV in Africa have oropharyngeal candidiasis, and C. albicans remains the most frequent cause of oropharyngeal candidiasis.Keywords
All Related Versions
Funding Information
- National Institutes of Health (D43TW010132, EU EDCTP (TMA2018CDF-2371))
This publication has 47 references indexed in Scilit:
- The syndemic burden of HIV/AIDS in Africa amidst the COVID‐19 pandemicImmunity, Inflammation and Disease, 2021
- Molecular identification of Candida isolates by Real‐time PCR‐high‐resolution melting analysis and investigation of the genetic diversity of Candida speciesJournal of Clinical Laboratory Analysis, 2020
- Dynamic study of oral Candida infection and immune status in HIV infected patients during HAARTArchives of Oral Biology, 2020
- Oropharyngeal candidiasis prevalence among HIV-infected patients at the teaching hospital of Treichville (Abidjan, Côte d’Ivoire)Journal of Medical Mycology, 2017
- Oral candidiasis among African human immunodeficiency virus-infected individuals: 10 years of systematic review and meta-analysis from sub-Saharan AfricaJournal of Oral Microbiology, 2017
- Virulence of oral Candida isolated from HIV-positive women with oral candidiasis and asymptomatic carriersOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2014
- Resistance of Candida spp. to antifungal drugs in the ICU: where are we now?Intensive Care Medicine, 2014
- Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and CameroonDiagnostic Microbiology and Infectious Disease, 2014
- Oral Candida isolates among HIV-infected subjects in NigeriaJournal of Microbiology, Immunology and Infection, 2011
- Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individualsDiagnostic Microbiology and Infectious Disease, 2002